DAT

Direct Coombs Test

Hemograma completo

Última revisión: 7 de abril de 2026. Enfoque de fuentes: contexto estándar de interpretación de laboratorio, material médico de referencia y orientación clínica o de salud pública cuando corresponde.

¿Qué es Direct Coombs Test?

The direct Coombs test, also known as the direct antiglobulin test (DAT), detects antibodies or complement proteins that are bound directly to the surface of red blood cells (RBCs) in vivo. The test is performed by washing the patient's red blood cells to remove unbound proteins, then adding anti-human globulin (AHG, also called Coombs reagent). If IgG antibodies or complement component C3d are attached to the RBC surface, the AHG will cross-link them, causing visible agglutination.

The DAT is a cornerstone of transfusion medicine and hematology. It is the primary test for diagnosing autoimmune hemolytic anemia (AIHA), evaluating transfusion reactions, investigating hemolytic disease of the fetus and newborn (HDFN), and detecting drug-induced immune hemolysis. The strength of the agglutination reaction is graded from 1+ to 4+, with stronger reactions generally correlating with more significant antibody coating, though clinical severity does not always parallel DAT strength.

Por qué importa

The direct Coombs test is essential for determining whether hemolysis (red blood cell destruction) is immune-mediated. A positive DAT in the setting of anemia and evidence of hemolysis (elevated LDH, low haptoglobin, elevated indirect bilirubin, reticulocytosis) confirms autoimmune hemolytic anemia and guides treatment. It is also critical in evaluating transfusion reactions—a newly positive DAT after transfusion suggests an acute or delayed hemolytic transfusion reaction. In newborns with jaundice, a positive DAT helps confirm hemolytic disease of the newborn.

Rangos de referencia normales

Grupo	Rango	Unidad
Adults and children	Negative	(no agglutination)

Los rangos de referencia pueden variar entre laboratorios. Compara siempre tus resultados con los rangos proporcionados por tu laboratorio.

Qué significan los niveles altos de DAT

Causas comunes

Warm autoimmune hemolytic anemia (IgG-mediated)
Cold agglutinin disease (complement-mediated)
Drug-induced immune hemolytic anemia (penicillin, cephalosporins, methyldopa)
Hemolytic transfusion reactions
Hemolytic disease of the fetus and newborn (Rh or ABO incompatibility)
Systemic lupus erythematosus
Chronic lymphocytic leukemia
Evans syndrome (AIHA + immune thrombocytopenia)

Posibles síntomas

Fatigue and weakness
Jaundice (yellowing of skin and eyes)
Dark urine (hemoglobinuria)
Pallor
Rapid heart rate
Shortness of breath
Splenomegaly (enlarged spleen)

Qué hacer: A positive DAT should be interpreted alongside clinical findings: complete blood count, reticulocyte count, haptoglobin, LDH, and indirect bilirubin. Monospecific DAT (testing separately for IgG and C3d) helps classify the type of immune hemolysis and guide therapy. Warm AIHA (IgG-positive) is typically treated with corticosteroids, while cold agglutinin disease (C3d-positive) responds poorly to steroids and may require rituximab. Drug causes should be investigated and the offending agent discontinued.

Qué significan los niveles bajos de DAT

Causas comunes

Normal result—no antibodies or complement bound to RBCs
DAT-negative autoimmune hemolytic anemia (rare, ~5% of AIHA cases)

Posibles síntomas

No symptoms associated with a negative DAT

Qué hacer: A negative DAT is the expected normal result. If clinical suspicion for immune hemolysis is high despite a negative DAT, more sensitive techniques such as flow cytometry, gel-based DAT, or eluate studies may detect low-level antibody coating not detected by standard tube methods.

¿Cuándo se recomienda la prueba de DAT?

Evaluating unexplained hemolytic anemia
Investigating a suspected transfusion reaction
Workup of neonatal jaundice or hemolytic disease of the newborn
Suspected drug-induced hemolysis
Autoimmune disease workup with cytopenias

Preguntas frecuentes

The direct Coombs test (DAT) detects antibodies already bound to the patient's red blood cells in vivo, used to diagnose immune hemolysis. The indirect Coombs test (IAT) detects free antibodies in the patient's serum that could potentially bind to donor red blood cells, used primarily in pretransfusion testing and prenatal screening.

Yes. Up to 0.1% of healthy blood donors and 1–15% of hospitalized patients have a positive DAT without clinical hemolysis. This can occur with certain medications, after intravenous immunoglobulin administration, or as an incidental finding. A positive DAT is clinically significant only when accompanied by evidence of hemolysis.

Not always. While a strongly positive DAT (3–4+) often indicates significant antibody coating, the clinical severity of hemolysis depends on many factors including antibody type, thermal amplitude, complement activation, and splenic function. Some patients with weakly positive DATs may have severe hemolysis, while others with strongly positive results may be asymptomatic.

Biomarcadores relacionados

IATIndirect Coombs Test HgbHemoglobina ReticReticulocyte Count

Lectura relacionada

Condiciones

Anemia →

Referencias y enfoque de revisión

Las páginas del glosario de biomarcadores son explicaciones educativas y deben interpretarse junto con los rangos de referencia y comentarios proporcionados por tu laboratorio y tu profesional de salud. Para conocer nuestros estándares editoriales y proceso de revisión, consulta nuestra Política editorial y nuestro Proceso de revisión de contenido.

¿Quieres analizar tus niveles de DAT?

Sube tus resultados de laboratorio para recibir un análisis instantáneo con IA de todos tus biomarcadores.

Subir resultados de laboratorio →

Aviso médico: Esta información es solo educativa y no sustituye el consejo, diagnóstico ni tratamiento médico profesional. Los rangos de referencia pueden variar entre laboratorios. Consulta siempre a tu profesional sanitario para interpretar tus resultados concretos.